GT-20x (Grid Therapeutics)

N/A

Report date: 2025/03/20 15:18:24

Base Information

Drug NameGT-20x (Grid Therapeutics)
Drug Alias Namerecombinant monoclonal antibody (Grid Therapeutics)GT-20x
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGrid Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesGrid Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A